RU2012111253A - Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта - Google Patents
Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта Download PDFInfo
- Publication number
- RU2012111253A RU2012111253A RU2012111253/15A RU2012111253A RU2012111253A RU 2012111253 A RU2012111253 A RU 2012111253A RU 2012111253/15 A RU2012111253/15 A RU 2012111253/15A RU 2012111253 A RU2012111253 A RU 2012111253A RU 2012111253 A RU2012111253 A RU 2012111253A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- composition according
- functional
- group
- bifidobacterium longum
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title claims abstract 8
- 229940009291 bifidobacterium longum Drugs 0.000 title claims abstract 8
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 38
- 241000894006 Bacteria Species 0.000 claims abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 6
- 208000035475 disorder Diseases 0.000 claims abstract 6
- 235000013305 food Nutrition 0.000 claims abstract 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000013406 prebiotics Nutrition 0.000 claims abstract 4
- 230000002496 gastric effect Effects 0.000 claims abstract 3
- 208000011580 syndromic disease Diseases 0.000 claims abstract 3
- 208000004998 Abdominal Pain Diseases 0.000 claims abstract 2
- 206010000060 Abdominal distension Diseases 0.000 claims abstract 2
- 206010000087 Abdominal pain upper Diseases 0.000 claims abstract 2
- 208000019901 Anxiety disease Diseases 0.000 claims abstract 2
- 241000186000 Bifidobacterium Species 0.000 claims abstract 2
- 206010010774 Constipation Diseases 0.000 claims abstract 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract 2
- 206010012735 Diarrhoea Diseases 0.000 claims abstract 2
- 229930091371 Fructose Natural products 0.000 claims abstract 2
- 239000005715 Fructose Substances 0.000 claims abstract 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract 2
- 229920001202 Inulin Polymers 0.000 claims abstract 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract 2
- 230000036506 anxiety Effects 0.000 claims abstract 2
- 208000024330 bloating Diseases 0.000 claims abstract 2
- 235000013325 dietary fiber Nutrition 0.000 claims abstract 2
- 235000015872 dietary supplement Nutrition 0.000 claims abstract 2
- 230000009429 distress Effects 0.000 claims abstract 2
- 201000006549 dyspepsia Diseases 0.000 claims abstract 2
- 201000000117 functional diarrhea Diseases 0.000 claims abstract 2
- 229930182830 galactose Natural products 0.000 claims abstract 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract 2
- 229940029339 inulin Drugs 0.000 claims abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims abstract 2
- 235000014655 lactic acid Nutrition 0.000 claims abstract 2
- 239000004310 lactic acid Substances 0.000 claims abstract 2
- 239000002417 nutraceutical Substances 0.000 claims abstract 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract 2
- 235000016709 nutrition Nutrition 0.000 claims abstract 2
- 229920001542 oligosaccharide Polymers 0.000 claims abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000001902 propagating effect Effects 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 235000021119 whey protein Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09168590.9A EP2289527B1 (en) | 2009-08-25 | 2009-08-25 | Bifidobacterium longum and functional GI disorders |
| EP09168590.9 | 2009-08-25 | ||
| PCT/EP2010/062320 WO2011023689A1 (en) | 2009-08-25 | 2010-08-24 | Bifidobacterium longum and functional gi disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012111253A true RU2012111253A (ru) | 2013-10-10 |
Family
ID=41508246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012111253/15A RU2012111253A (ru) | 2009-08-25 | 2010-08-24 | Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта |
Country Status (17)
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2110028A1 (en) | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
| ES2664828T3 (es) | 2009-08-25 | 2018-04-23 | Nestec S.A. | Bifidobacterium longum y trastornos GI funcionales |
| EP2452576A1 (en) * | 2010-11-11 | 2012-05-16 | Nestec S.A. | Extruded non-replicating probiotic micro-organisms and their health benefits |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
| CN105407728A (zh) | 2013-07-21 | 2016-03-16 | 霍勒拜欧姆公司 | 用于微生物组表征、监测和治疗的方法和系统 |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| EP3212001A4 (en) | 2014-10-31 | 2018-04-25 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| WO2016183535A1 (en) | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
| WO2016198528A1 (en) | 2015-06-11 | 2016-12-15 | Nestec S.A. | Dietary supplement |
| EP3344269A1 (en) * | 2015-08-31 | 2018-07-11 | Nestec S.A. | Methods and compositions using bifidobacterium longum to optimize breastfeeding |
| BR112018000934B1 (pt) * | 2015-08-31 | 2022-02-01 | Société des Produits Nestlé S.A. | Usos de bifidobacterium longum para tratar ou prevenir sintomas depressivos |
| BR112018000786B1 (pt) * | 2015-08-31 | 2022-06-14 | Société des Produits Nestlé S.A. | Uso de b. longum atcc baa-999 na preparação de composição comestível para tratar depressão |
| WO2017071716A1 (en) | 2015-10-28 | 2017-05-04 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
| EP3368046B1 (en) | 2015-10-28 | 2022-07-27 | Glycom A/S | Synthetic composition and method for modulating brain function and behaviour |
| US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
| JP6353478B2 (ja) * | 2016-03-28 | 2018-07-04 | 日清食品ホールディングス株式会社 | セロトニン分泌促進能力を有するビフィズス菌 |
| CN107050062A (zh) * | 2016-11-08 | 2017-08-18 | 江西益盟科技有限公司 | 治疗便秘的乳酸菌组合物及其制备方法 |
| CN106579414A (zh) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解运动性腹泻的组合物 |
| WO2018158309A1 (en) | 2017-02-28 | 2018-09-07 | Alimentary Health Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
| US11529381B2 (en) | 2017-02-28 | 2022-12-20 | Precisionbiotics Group Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
| EP3618843A1 (en) * | 2017-05-05 | 2020-03-11 | Société des Produits Nestlé S.A. | Treatment of infant colic |
| CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
| US20190298783A1 (en) | 2018-03-28 | 2019-10-03 | Morinaga Milk Industry Co., Ltd. | Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress |
| CA3106315A1 (en) | 2018-07-19 | 2020-01-23 | Pendulum Therapeutics, Inc. | Methods and compositions for microbial engraftment |
| AU2020299976B2 (en) * | 2019-07-01 | 2025-08-21 | Société des Produits Nestlé S.A. | Serpin production |
| JP2021014422A (ja) * | 2019-07-11 | 2021-02-12 | 日清ファルマ株式会社 | 便性改善剤 |
| JP2021014421A (ja) * | 2019-07-11 | 2021-02-12 | 日清ファルマ株式会社 | Ｑｏｌ改善剤 |
| CN111187734A (zh) * | 2019-12-25 | 2020-05-22 | 生合生物科技（扬州）有限公司 | 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用 |
| JP7761591B2 (ja) * | 2020-05-20 | 2025-10-28 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ビフィドバクテリウム・ロンガムによる不溶性繊維の発酵性及び短鎖脂肪酸産生の改善 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH637297A5 (fr) | 1978-12-05 | 1983-07-29 | Nestle Sa | Microbille comprenant un microorganisme et son procede de fabrication. |
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| DE10008279A1 (de) * | 2000-02-23 | 2001-08-30 | Meggle Gmbh | Milchzucker enthaltende Zusammensetzung |
| US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
| PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
| CA2458936A1 (en) * | 2001-08-31 | 2003-03-13 | Nutricopia, Inc. | Nutritional frozen dessert and methods of menufacture |
| EP1384483A1 (en) | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| AU2003303894A1 (en) * | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| JP2004262773A (ja) * | 2003-02-17 | 2004-09-24 | Ryoshoku Kenkyukai | 免疫機能改善を目的としたビフィズス菌製剤 |
| US20040265279A1 (en) * | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
| ATE433674T1 (de) * | 2003-06-23 | 2009-07-15 | Nestec Sa | Säuglingsnährpräparat oder folgemilch |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
| US8134942B2 (en) * | 2005-08-24 | 2012-03-13 | Avaak, Inc. | Communication protocol for low-power network applications and a network of sensors using the same |
| CA2628495A1 (en) * | 2005-11-14 | 2007-05-18 | Unilever Plc | Edible product containing ginseng polysaccharides and beneficial bacteria |
| JP2007169200A (ja) * | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
| CN101420965B (zh) * | 2006-02-15 | 2013-08-07 | 雀巢产品技术援助有限公司 | 长双歧杆菌在制备预防和治疗炎症的药物中的用途 |
| PL1993576T3 (pl) | 2006-03-07 | 2016-04-29 | Nestec Sa | Mieszanina synbiotyczna |
| EP1961308A1 (en) * | 2007-02-21 | 2008-08-27 | Nestec S.A. | Nutritionally balanced frozen dessert |
| EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
| EP1974735A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
| US9113641B2 (en) * | 2007-12-06 | 2015-08-25 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
| RU2010129825A (ru) * | 2007-12-17 | 2012-01-27 | Юриверсити Оф Флорида Рисерч Фаундейшн, Инк. (Us) | Материалы и способы для лечения патологической пролиферации глазных сосудов |
| EP2110028A1 (en) * | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
| WO2010008272A1 (en) * | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
| ES2664828T3 (es) | 2009-08-25 | 2018-04-23 | Nestec S.A. | Bifidobacterium longum y trastornos GI funcionales |
| CN112074193A (zh) * | 2018-01-29 | 2020-12-11 | 精密生物集团有限公司 | 一种用于预防和治疗肠易激综合征的组合产品 |
-
2009
- 2009-08-25 ES ES09168590.9T patent/ES2664828T3/es active Active
- 2009-08-25 EP EP09168590.9A patent/EP2289527B1/en not_active Revoked
- 2009-08-25 DK DK09168590.9T patent/DK2289527T3/en active
- 2009-08-25 TR TR2018/07143T patent/TR201807143T4/tr unknown
-
2010
- 2010-08-24 US US13/391,343 patent/US10028981B2/en active Active
- 2010-08-24 CN CN201610417206.3A patent/CN106072658A/zh active Pending
- 2010-08-24 IN IN1638DEN2012 patent/IN2012DN01638A/en unknown
- 2010-08-24 BR BR112012004046-4A patent/BR112012004046B1/pt active IP Right Grant
- 2010-08-24 JP JP2012526036A patent/JP2013503130A/ja active Pending
- 2010-08-24 SG SG2012011474A patent/SG178499A1/en unknown
- 2010-08-24 RU RU2012111253/15A patent/RU2012111253A/ru not_active Application Discontinuation
- 2010-08-24 MX MX2012002402A patent/MX2012002402A/es not_active Application Discontinuation
- 2010-08-24 CA CA2772163A patent/CA2772163C/en active Active
- 2010-08-24 CN CN2010800480174A patent/CN102573863A/zh active Pending
- 2010-08-24 EP EP10747451A patent/EP2470188A1/en active Pending
- 2010-08-24 WO PCT/EP2010/062320 patent/WO2011023689A1/en not_active Ceased
- 2010-08-24 AU AU2010288546A patent/AU2010288546B2/en active Active
-
2012
- 2012-02-24 CL CL2012000487A patent/CL2012000487A1/es unknown
- 2012-03-23 ZA ZA2012/02155A patent/ZA201202155B/en unknown
-
2015
- 2015-11-09 JP JP2015219799A patent/JP2016074682A/ja active Pending
-
2017
- 2017-08-18 JP JP2017158082A patent/JP7096652B6/ja active Active
-
2018
- 2018-06-29 US US16/023,503 patent/US11452745B2/en active Active
-
2020
- 2020-06-18 JP JP2020105621A patent/JP2020183385A/ja not_active Withdrawn
-
2022
- 2022-04-27 US US17/730,891 patent/US11957720B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012111253A (ru) | Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта | |
| JP6985231B2 (ja) | プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用 | |
| JP6444358B2 (ja) | ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法 | |
| RU2543815C2 (ru) | Питательные композиции, содержащие лактоферрин и пробиотики, и наборы из их частей | |
| RU2012117804A (ru) | Bifidobacterium longum atcc baa-999 (bl999) и контролирование веса | |
| ES2641364T3 (es) | Probióticos, IgA secretor e inflamación | |
| JP6796070B2 (ja) | 難消化性成分を含む飲食品および大腸内水素ガス産生剤 | |
| JP2012520325A5 (cg-RX-API-DMAC7.html) | ||
| RU2018107583A (ru) | Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании | |
| JP2014512376A (ja) | 胃酸過多症の薬理学的処置中に失われる胃のバリア効果を回復させることができるプロバイオティック細菌を含む組成物 | |
| CN109287920A (zh) | 一种多元维生素与多联益生菌的固体饮料及其制作方法 | |
| RU2018107612A (ru) | Питательные композиции и детские смеси, включающие bifidobacterium animalis подвида lactis и необязательно смесь олигосахаридов, для индукции кишечной микробиоты, которая похожа на микробиоту младенцев, находящихся на грудном вскармливании | |
| RU2019105764A (ru) | Питательные композиции и детские смеси, содержащие смесь олигосахаридов и необязательно bifidobacterium lactis для профилактики, лечения или снижения степени тяжести диареи, не связанной с ротавирусом | |
| RU2011150189A (ru) | Профилактика и лечение аллергической диареи | |
| Cuvas-Limón et al. | Aloe vera and probiotics: a new alternative to symbiotic functional foods | |
| US20240316131A1 (en) | Physiologically acceptable yeast compositions and uses thereof | |
| Horvath et al. | Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders | |
| CN103284265A (zh) | 一种具有改善肠道菌群、通便作用的固体饮料 | |
| Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
| CN115039886A (zh) | 一种双歧杆菌微胶囊的制备方法及应用 | |
| Sharma et al. | Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics | |
| CN116349819A (zh) | 菊芋菊粉益生菌保健固体饮料 | |
| Mera et al. | Biotechnological innovations in pro-, pre-, and synbiotics | |
| CN118541038A (zh) | 生理学上可接受的酵母菌组合物及其用途 | |
| CN116349815A (zh) | 一种能够调节肠道菌群的活菌型益生菌固体饮料生产配方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20141006 |